NIH-funded research R01 grant

Understanding the genetic factors behind nonalcoholic fatty liver disease.

Official title: Genetic Regulation of Nonalcoholic Fatty Liver Disease

Funded at University of California, San Francisco · NIH-10804636 · Data updated 2026-11-12

This study is looking at how our genes might affect nonalcoholic fatty liver disease (NAFLD) by using special cells from patients to see how certain genetic differences can lead to fat buildup in the liver, helping us learn more about why some people may have more severe cases of this condition.

More Fatty Liver research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJune 8, 2021
Project endMarch 31, 2026
Funding year2024
Award (this year)$537,831
NIH project number5R01DK130391-04
Project IDNIH-10804636 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are at risk for or diagnosed with nonalcoholic fatty liver disease.

Less likely to help

Patients with alcoholic liver disease or those without any genetic predisposition to NAFLD may not benefit from this research.

What this research studies

This research investigates the genetic regulation of nonalcoholic fatty liver disease (NAFLD), a condition affecting a significant portion of American adults. By utilizing patient-derived induced pluripotent stem cells (iPSCs), the study aims to explore how specific genetic variants contribute to lipid accumulation in the liver. The researchers will analyze these cells in both their undifferentiated state and after differentiation into liver-like cells to better understand the genetic predisposition to NAFLD. This innovative approach seeks to uncover new genetic factors that may influence the severity of the disease.

Why it matters

Potential benefit: If successful, this research could lead to the development of targeted therapies for nonalcoholic fatty liver disease.

How similar studies have gone: Previous research has shown promise in using patient-derived cell models to study genetic diseases, indicating potential success for this novel approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Medina, Marisa Wong — University of California, San Francisco
  • Study coordinator: Medina, Marisa Wong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.